Current Perceptions of Access

To Innovate Therapies In Canada

Needs assessment results

Access to Innovation



21 Mar 2017

Research led by:

Dr. John Kuruvilla (Princess Margaret Cancer Centre)

The CARE™ Faculty recently conducted a needs assessment directed at Canadian oncologists and hematologists in the late Fall of 2017. The key focus of the needs assessment was assessing the potential challenges that specialists face in current regulatory processes.

There has been a strong, pan-Canadian response to this needs assessment suggesting high levels of interest and relevance.

This publication highlights the current state of drug approval processes, access to innovative medicines and key challenges that specialists face in the Canadian healthcare landscape today.